Neuropathological studies have shown that the typical neurofibrillary pathology of hyperphosphorylated tau protein in Alzheimer's disease (AD) preferentially affects specific brain regions whereas others remain relatively spared. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.